Liminatus Pharma (LIMN) Financials: Revenue & Earnings
LIMN$3.03+0.14 +4.84%
$4.07M
Market Cap
—
P/E
—
Forward P/E
—
Score
Liminatus Pharma (LIMN) Financials: Revenue & Earnings
LIMN price $3.03 +0.14 +4.84%
- Ticker
- LIMN
- Price
- $3.03
- Change
- +0.14 +4.84%
- Market cap ?
- $4.07M
- Beta ?
- 0.75
- Sector
- Healthcare
- Industry
- Biotechnology
Fair value
LIMN fair value $251.57. Price $3.03. Price is 99% below fair value.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Model uncertainty high for this stock
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-08-14 | -1.50 | — | — | — |
| 2026-05-15 | -0.03 | — | — | — |
| 2026-03-31 | -0.03 | — | — | — |
| 2025-11-13 | -0.07 | — | — | — |
| 2025-10-03 | 0.24 | — | — | — |
| 2025-05-31 | -127.50 | — | — | — |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-07-02 | Valetudo Therapeutics LLC | Buy | 3.45M | $0.20 | 689.79K |
| 2026-06-24 | Valetudo Therapeutics LLC | Sell | 4.37M | — | — |
| 2026-06-24 | Ewon Comfortech Co., Ltd. | Other | 0 | — | — |
| 2025-07-10 | Lemons II Philip Wayne | Other | 0 | — | — |
| 2025-07-10 | Baek Richard JaiHwan | Other | 0 | — | — |
| 2025-04-30 | Iris Acquisition Holdings LLC | Other | 0 | — | — |
| 2025-04-30 | KH Feelux Co., Ltd | Other | 0 | — | — |
| 2025-04-30 | Valetudo Therapeutics LLC | Other | 0 | — | — |
| 2025-04-30 | Lee Eun Sook | Other | 0 | — | — |
| 2025-04-30 | Baek Ji Yeon | Other | 0 | — | — |
| 2025-04-30 | Kim Chris | Other | 0 | — | — |
| 2025-04-30 | Choi Beom Kyu | Other | 0 | — | — |
| 2025-04-30 | Yoo Byong Chul | Other | 0 | — | — |
| 2025-04-30 | Lee Sang-Jin | Other | 0 | — | — |
| 2025-04-30 | Fernandez Nicholas | Other | 0 | — | — |
| 2025-04-30 | Dam Scott | Other | 0 | — | — |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 14, holders -1 vs prior quarter. Ownership 3.98%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| CYGNUS CAPITAL ADVISORS, LLC | 329.33K | -20.67K | -5.90% | 36.00K |
| XTX TOPCO LTD | 221.84K | 221.84K | New | 24.49K |
| GEODE CAPITAL MANAGEMENT, LLC | 138.42K | 20.64K | +17.52% | 15.28K |
| CITADEL ADVISORS LLC | 56.09K | -621.43K | -91.72% | 6.19K |
| VANGUARD CAPITAL MANAGEMENT LLC | 50.44K | 0 | 0.00% | 5.55K |
| GOLDMAN SACHS GROUP INC | 40.22K | 40.22K | New | 4.44K |
| STONEX GROUP INC. | 26.06K | 26.06K | New | 3.93K |
| VANGUARD FIDUCIARY TRUST CO | 22.98K | 0 | 0.00% | 2.53K |
| STATE STREET CORP | 19.00K | 0 | 0.00% | 2.10K |
| UBS GROUP AG | 16.73K | -37.85K | -69.35% | 1.84K |
| VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC | 13.15K | -21.56K | -62.12% | 1.45K |
| TOWER RESEARCH CAPITAL LLC (TRC) | 7.09K | -474 | -6.26% | 783 |
| BARCLAYS PLC | 4.29K | 4.29K | New | 474 |
| BLACKROCK, INC. | 313 | -12.94K | -97.64% | 35 |
| JANE STREET GROUP, LLC | 0 | -71.32K | -100.00% | 0 |
| TWO SIGMA SECURITIES, LLC | 0 | -22.04K | -100.00% | 0 |
| FARTHER FINANCE ADVISORS, LLC | 0 | -14 | -100.00% | 0 |
| CITIGROUP INC | 0 | -6.77K | -100.00% | 0 |
| VIRTU FINANCIAL LLC | 0 | -27.47K | -100.00% | 0 |
Earnings and financials
Liminatus Pharma, Inc. Class A Common Stock (LIMN) trades at $3.03, with a market cap of $4.07M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Insights · Dividends · Forecast · Financials · Learn